ArticleExperimental and therapeutic medicine2016

CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response.

Huilong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.